1727 Pill - white oval
Pill with imprint 1727 is White, Oval and has been identified as Tofacitinib Citrate Extended-Release 22 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Tofacitinib is used in the treatment of Ankylosing Spondylitis; Rheumatoid Arthritis; Psoriatic Arthritis; Ulcerative Colitis; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Tofacitinib 22 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1727
Tofacitinib Citrate Extended-Release
- Imprint
- 1727
- Strength
- 22 mg
- Color
- White (white to off-white)
- Shape
- Oval (film-coated)
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Zydus Lifesciences Limited
- National Drug Code (NDC)
- 70710-1727
Related images for "1727"
More about tofacitinib
- Check interactions
- Compare alternatives
- Reviews (173)
- Imprints, shape & color data
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.